✦ LIBER ✦

204 Phase II activity of cisplatin (CDDP) plus ifosfamide (IFO) and gemcitabine (GEM) in non small cell lung cancer (NSCLC): Preliminary results

✍ Scribed by Barneto, I.C.; De la Haba, J.; Gosálbez, B.; Artal, A.; Anton, A.; Aranda, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

231 Gemcitabine (GEM)-cisplatin (CDDP)-v

✍ Comella, P.; Panza, N.; Frasci, G.; Pacilio, C.; Nicolella, G.P.; Natale, M.; De 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Phase II study of ifosfamide (IFX), cisp

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 146 KB

29 A phase II trial — Gemcitabine plus c

✍ Rubio, Jaime E.; Sahagún, Guillermo; Rodriguez, Jorge D.; Figueroa, Francisco; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

67 Phase II activity of gemcitabine + ci

✍ Gonzalez-Barón, M.; Gracia, M.; García Girón, C.; Lizón, J.; Constenla, M.; Aguí 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 145 KB

159 Phase II trial of gemcitabine in com

✍ Mohedano, N.; Sanchez-Rovira, P.; Medina, B.; Flores-Gonzalez, E.; Moreno, M.A.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

A phase II trial of oral UFT plus cispla

✍ Saito, Junichi; Nakai, Yushi; Saijo, Yasuo; Nukiwa, Toshihiro; Koinumaru, Sadahi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 87 KB